The journal and Chief Editors retract the 27 November 2020 article cited above.
Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.
This retraction was approved by the Chief Editors of Frontiers in Endocrinology and the Chief Executive Editor of Frontiers. The authors agreed with this retraction.
Summary
Keywords
MicroRNA-216a-3p, Interferon-α2, Toll-like receptor signaling pathway, type 2 diabetes mellitus, cardiomyocytes, proliferation
Citation
Frontiers Editorial Office (2021) Retraction: Overexpression of microRNA-216a-3p Accelerates the Inflammatory Response in Cardiomyocytes in Type 2 Diabetes Mellitus by Targeting IFN-α2. Front. Endocrinol. 12:839850. doi: 10.3389/fendo.2021.839850
Received
20 December 2021
Accepted
20 December 2021
Published
30 December 2021
Approved by
Pierre De Meyts, Université Catholique de Louvain Brussels, Belgium
Volume
12 - 2021
Updates
Copyright
© 2021 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org
This article was submitted to Molecular and Structural Endocrinology, a section of the journal Frontiers in Endocrinology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.